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Abstract: 
 
Background and Objectives: The identification of characteristics that predict clinical and 
functional outcomes in patients with schizophrenia and related psychotic disorders is essential 
for enhancing our understanding of the pathophysiology and the treatment of the disorder. The 
present study employed a retrospective design to examine the predictive validity of demographic, 
clinical, and psychosocial characteristics of first-episode patients on diagnosis, presence of 
residual psychotic symptoms, and number of psychotic episodes three to five years later. 
Methods: Information on baseline predictor variables and outcome was obtained from the 
clinical records of 44 patients who had their first psychotic episode between 1999 and 2003 and 
whose available follow-up period was at least 3 years long (mean = 5.7 years, SD = 1.3 years). 
Results: Male gender, single marital status, and poor premorbid adjustment were significantly 
associated with residual symptoms at follow-up. Poor insight at onset was significantly 
associated with subsequent relapses. Diagnosis of schizophrenia (as opposed to other psychotic 
disorders) at the follow-up assessment showed no significant association with any of the baseline 
predictors. Conclusions: Consistent with previous findings, the constellation of male gender, 
single status, poor premorbid adjustment and poor insight appeared to predict especially poor 
outcome. Residual symptoms appear to be an especially useful index of clinical and functional 
status for examining the course and outcome of first-episode psychosis. 
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ABSTRACT – Background and Objectives: The identification of characteristics that pre-
dict clinical and functional outcomes in patients with schizophrenia and related psychotic
disorders is essential for enhancing our understanding of the pathophysiology and the
treatment of the disorder. The present study employed a retrospective design to examine
the predictive validity of demographic, clinical, and psychosocial characteristics of first-
episode patients on diagnosis, presence of residual psychotic symptoms, and number of
psychotic episodes three to five years later.
Methods: Information on baseline predictor variables and outcome was obtained from
the clinical records of 44 patients who had their first psychotic episode between 1999 and
2003 and whose available follow-up period was at least 3 years long (mean = 5.7 years,
SD = 1.3 years).
Results: Male gender, single marital status, and poor premorbid adjustment were sig-
nificantly associated with residual symptoms at follow-up. Poor insight at onset was sig-
nificantly associated with subsequent relapses. Diagnosis of schizophrenia (as opposed to
other psychotic disorders) at the follow-up assessment showed no significant association
with any of the baseline predictors.
Introduction
Schizophrenia is one of the most disabling
mental disturbances; however, it can no lon-
ger be conceived as a hopeless and ine-
vitable pathway to deterioration1. During the
five years after the first psychotic episode
(the so-called “critical period”), most pa-
tients are likely to relapse and/or present
residual symptoms. Eventually, however,
psychotic disorders appear to reach a plateau
and follow a more stable course2,3. Never-
theless, some studies have documented great
heterogeneity in illness course, such that be-
tween 12-22% of patients never relapse or
present residual symptoms4. The identifica-
tion of characteristics that predict clinical
and functional outcomes in newly diagnosed
psychotic patients should enhance our un-
derstanding of such disorders and provide
guidance for treatment.
Research and intervention programs in
early psychosis aim to reduce suicide and re-
lapse rates, prevent social and cognitive de-
terioration and ameliorate persisting symp-
toms5,6. In this study area, outcome has been
defined by a variety of clinical, functional
and quality of life measures5. A widely used
outcome criterion, and perhaps the most
available, is diagnosis, which can be reli-
ably established after approximately six
months of onset7. Schizophrenic psychoses
show, compared to schizoaffective and affec-
tive psychoses, a poorer global outcome,
more deteriorating course, greater presence
of negative symptoms, and more persistent
impairments in several aspects of social life,
such as communication and cognitive func-
tions8,9. Illness course is also extensively re-
ported as an outcome measure, varying from
a full recovery to a chronic deteriorating
course7,10-12. Some studies, simplifying the
course of psychosis as “poor” or “good”,
have defined course by relying either on the
presence of residual symptoms4,13 or on the
occurrence of subsequent relapses14. Howev-
er, there is a shortage of studies comparing
the impact of using either one or the other,
particularly on their ability to evaluate the
utility of putative prognostic indicators.
Apart from outcome definitions, studies
have also diverged in the analysis of pre-
morbid and first-episode characteristics that
might be predictive of outcome. Sociode-
mographic variables, clinical features, con-
ditions of the premorbid phase, context of
presentation of the first episode of psy-
chosis, and type of treatment have been the
most common factors related to early and
long-term outcome. Literature on this topic
is abundant, suggesting that among many
factors, early age at onset, male gender, sin-
gle status, poor premorbid adjustment, lack
of insight, and symptom severity at onset,
are highly related to poor outcome2,15, though
not all findings concur5,6.
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Conclusions: Consistent with previous findings, the constellation of male gender, sin-
gle status, poor premorbid adjustment and poor insight appeared to predict especially poor
outcome. Residual symptoms appear to be an especially useful index of clinical and func-
tional status for examining the course and outcome of first-episode psychosis.
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Research so far has identified important
predictors of outcome. Nevertheless, and to
the best of our knowledge, there is a short-
age of studies analysing the association of
premorbid and first episode variables with
different outcome definitions. Therefore,
this study aims at (i) replicating the prog-
nostic value of factors previously related to
the early course of psychosis in retrospec-
tively assessed first-episode psychotic pa-
tients, and (ii) assessing their prognostic
value according to three different outcome
criteria (final diagnosis, presence of psy-
chotic residual symptoms, and number of
psychotic episodes).
Methods
Design and Case Selection
This is a retrospective case series study
focusing on the early course of psychosis in
a cohort of patients from an outpatient clin-
ic in Barcelona, Spain. Data were collected
through the review of clinical files after ob-
taining formal authorization and ethical ap-
proval from the Hospital Committee. Inclu-
sion criteria were: (1) occurrence of a first
episode of psychosis between 1999 and
2003; (2) age at onset between 18-45 years;
and (3) a primary current DSM-IV-TR7 di-
agnosis of schizophrenia or other psychotic
disorders (schizophreniform, schizoaffec-
tive, delusional, brief, or not otherwise spe-
cified). Exclusion criteria were: (1) psy-
choses of affective, organic, or toxic type,
(2) an evident intellectual disorder, and (3)
no follow-up information available. We
identified 44 first-episode patients who met
the criteria for inclusion in the study. These
included 28 men and 16 women, with an av-
erage age at first episode of 27.6 years (SD
= 7.6). All cases included had an available
follow up of at least 3 years (mean = 5.7, SD
= 1.3). Most patients (61.4%) had never in-
terrupted their contact with the mental
health service for any period of six months
or longer. All patients had received antipsy-
chotic medication.
Measures and Variables
Based upon findings in previous stud-
ies4,13,14, the predictors identified at the first
episode included (1) sociodemographic da-
ta, (2) premorbid phase, (3) features of the
context of the first episode, and (4) dimen-
sions of psychotic psychopathology. For
psychopathology clinicians rated the pres-
ence of symptoms corresponding to each of
its three dimensions (psychoticism, disorga-
nization, and negative symptoms) by trans-
lating the clinical records information into
PANNS selected items16.
Outcome was classified according to three
criteria. First, current diagnosis was estab-
lished according to DSM-IV-TR7 criteria by
experienced senior clinicians (EV, JMB,
MM). After reaching clinical consensus, diag-
noses were dichotomized into: 1) schizophre-
nia and, 2) other psychoses. A second criterion
grouped cases as 1) with residual symptoms
or, 2) with no residual symptoms at the time
of the outcome assessment. A third criterion
considered the number of psychotic episodes
during the follow-up period (including the
initial episode), classifying cases as 1) single
episode or, 2) multiple episodes.
Results
Table I presents a series of binary (sociode-
mographic variables) and multinomial (pre-
morbid phase, context of the first episode, and
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Table I
Logistic regression analyses of baseline variables predicting the three different outcome criteria
Outcome: Last diagnosis
VARIABLE Schizophrenia Other psychosis Odds Ratio
N = 29 N = 15 (95% CI)
Category / Range Mean (SD) or % Mean (SD) or %
1. SOCIODEMOGRAPHIC VARIABLES
Age at onset (years) 28.6 (7.9) 25.9 (7.0) 0.95
(0.87 – 1.04)
Gender 65.5% / 34.5% 60.0% / 40.0% 1.27
Male / Female (0.35 – 4.58)
Marital status 62.1% / 37.9% 66.7% / 33.3% 0.82
Single / ever married (0.22 – 3.03)
Educational level 55.2% / 44.8% 53.3% / 46.7% 1.08
Basic / Medium or higher (0.31 – 3.76)
Work or study 79.3% / 20.7% 80.0% / 20.0% 0.96
Yes / No (0.20 – 4.52)
2. PREMORBID PHASE VARIABLES
Premorbid adjustment 69.0% / 31.0% 60.0% / 40.0% 1.34
Poor / Good (0.35 – 5.14)
Identified trigger 44.8% / 55.2% 33.3% / 66.7% 1.57
Yes / No (0.41 – 5.98)
Type of onset 55.2% / 44.8% 66.7% / 33.3% 0.61
Sudden, Acute / Insidious (0.16 – 2.25)
3. CONTEXT OF FIRST PSYCHOTIC
EPISODE VARIABLES
Hospitalization 55.2% / 44.8% 53.3% / 46.7% 0.96
Yes / No (0.26 – 3.58)
Substance abuse 34.5% / 65.5% 40.0% / 60.0% 0.84
Yes / No (0.22 – 3.18)
Level of insight 79.3% / 20.7% 60.0% / 40.0% 2.54
Null / Partial (0.63 – 10.27)
4. PSYCHOPATHOLOGY SYMPTOM
COUNTS
Psychoticism 2.1 (0.9) 2.2 (0.9) 1.21
(0.50 – 2.91)
Disorganization 0.8 (0.5) 0.7 (0.5) 0.58
(0.12 – 2.74)
Negative 1.7 (1.1) 1.1 (1.1) 0.60
(0.32 – 1.11)
*p < 0.05
Note: separate regressions were computed for premorbid phase, context, and psychopathology variables
with the predictors for each analysis entered simultaneously.
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Outcome: Presence of residual symptoms (R.S.)
VARIABLE With R.S. With NO R.S. Odds Ratio
n = 36 n = 8 (95% CI)
Category / Range Mean (SD) or % Mean (SD) or %
1. SOCIODEMOGRAPHIC VARIABLES
Age at onset (years) 27.3 (7.8) 29.4 (6.8) 1.04
(0.94 – 1.15)
Gender 72.2% / 27.8% 25.0% / 75.0% 7.80*
Male / Female (1.34 – 45.28)
Marital status 72.2% / 27.8% 25.0% / 75.0% 7.80*
Single / ever married (1.34 – 45.28)
Educational level 50.0% / 50.0% 75.0% / 25.0% 0.33
Basic / Medium or higher (0.06 – 1.88)
Work or study 75.0% / 25.0% 100.0% / 0.0% 0.00
Yes / No (0.00 – 0.00)
2. PREMORBID PHASE VARIABLES
Premorbid adjustment 75.0% / 25.0% 25.0% / 75.0% 7.77*
Poor / Good (1.22–49.44)
Identified trigger 47.2% / 52.8% 12.5% / 87.5% 4.90
Yes / No (0.48 – 49.69)
Type of onset 55.6% / 44.4% 75.0% / 25.0% 0.36
Sudden, Acute / Insidious (0.05 – 2.49)
3. CONTEXT OF FIRST PSYCHOTIC
EPISODE VARIABLES
Hospitalization 52.8% / 42.2% 62.5% / 37.5% 0.48
Yes / No (0.08 – 2.82)
Substance abuse 36.1% / 63.9% 37.5% / 62.5% 1.25
Yes / No (0.22 – 7.23)
Level of insight 77.8% / 22.2% 50.0% / 50.0% 4.21
Null / Partial (0.76 – 23.22)
4. PSYCHOPATHOLOGY SYMPTOM
COUNTS
Psychoticism 2.1 (0.9) 2.4 (0.7) 1.27
(0.48 – 3.36)
Disorganization 0.7 (0.5) 1.0 (0.0) 7.26
(0.58 – 90.60)
Negative 1.5 (1.1) 1.3 (1.2) 0.74
(0.34 – 1.63)
*p < 0.05
Note: separate regressions were computed for premorbid phase, context, and psychopathology variables
with the predictors for each analysis entered simultaneously.
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Outcome: Number of episodes
VARIABLE Single episode Multiple episodes Odds Ratio
n = 14 n = 30 (95% CI)
Category / Range Mean (SD) or % Mean (SD) or %
1. SOCIODEMOGRAPHIC VARIABLES
Age at onset (years) 28.5 (6.7) 27.3 (8.1) 1.02
(0.94 – 1.11)
Gender 64.3% / 35.7% 63.3% / 36.7% 0.96
Male / Female (0.26 – 3.60)
Marital status 50.0% / 50.0% 70.0% / 30.0% 2.33
Single / ever married (0.63 – 8.62)
Educational level 57.1% / 42.9% 53.3% / 46.7% 0.86
Basic / Medium or higher (0.24 – 3.08)
Work or study 78.6% / 21.4% 80.0% / 20.0% 1.09
Yes / No (0.23 – 5.19)
2. PREMORBID PHASE VARIABLES
Premorbid adjustment 71.4% / 28.6% 63.3% / 36.7% 0.64
Poor / Good (0.15 – 2.64)
Identified trigger 35.7% / 64.3% 43.3% / 56.7% 1.48
Yes / No (0.38 – 5.72)
Type of onset
Sudden, Acute / Insidious 50.0% / 50.0% 63.3% / 36.7% 1.70
(0.47 – 6.21)
3. CONTEXT OF FIRST PSYCHOTIC
EPISODE VARIABLES
Hospitalization 35.7% / 64.3 % 63.3% / 36.7% 2.54
Yes / No (0.61 – 10.48)
Substance abuse 28.6% / 71.4% 40.0% / 60.0% 1.72
Yes / No (0.38 – 7.78)
Level of insight 50.0% / 50.0% 83.3% / 16.7% 4.88*
Null / Partial (1.08 – 21.97)
4. PSYCHOPATHOLOGY SYMPTOM
COUNTS
Psychoticism 2.0 (0.8) 2.2 (0.9) 0.80
(0.38 – 1.71)
Disorganization 0.6 (0.6) 0.8 (0.4) 0.68
(0.18 – 2.53)
Negative 1.6 (1.2) 1.4 (1.1) 1.26
(0.70 – 2.26)
*p < 0.05
Note: separate regressions were computed for premorbid phase, context, and psychopathology variables
with the predictors for each analysis entered simultaneously.
psychopathology) logistic regressions com-
puted to analyze the prediction of the three
outcomes by the selected prognostic variables.
Patients who are male, who had never
been married nor lived with a stable partner
at the time of first admission, or had a poor
premorbid adjustment, were significantly
more likely to suffer from residual symp-
toms at the outcome assessment. Poor in-
sight at first-episode predicted further re-
lapses (multiple psychotic episodes).
Consideration was given to creating a
composite outcome measure based upon the
three outcome variables. However, the out-
come variables did not correlate significantly
with one another and an additive combina-
tion (reverse scoring of number of episodes)
not surprisingly produced an unreliable va-
riable (coefficient alpha = 0.35). Further-
more, it was not entirely clear what the na-
ture of the composite variable was. As an
alternative, a principal component analysis
was conducted on the three outcome vari-
ables resulting in one interpretable compo-
nent that accounted for 44% of the variance.
This continuous variable was transformed to
remove positive skew and correlated with the
prognostic variables. However, only level of
insight at the first episode correlated signifi-
cantly with the outcome factor (with good in-
sight associated with the non-psychotic/less
residual/fewer episodes pole of the factor).
Therefore, the possibility of constructing a
composite outcome measure did not turn out
to be informative and suggests the need of
qualitatively taking into account a profile as-
sociated with the 3 outcome measures.
Discussion
This longitudinal retrospective study cor-
roborates the significant association of male
gender, single status, and poor premorbid ad-
justment with poor outcome as defined by the
subsequent presence of residual symptoms.
Also, poor insight was associated with the oc-
currence of multiple psychotic episodes. Di-
mensions of psychopathology were not asso-
ciated to any of the three outcome definitions.
Outcome defined by final diagnosis could
not be predicted by any of the selected base-
line factors.
Predictors of outcome
Both biological and psychosocial hy-
potheses have been put forward to explain
gender differences in psychosis outcome (in
this study indicated by males showing more
residual symptomatology). Some authors
have suggested that gender does not have a
direct effect on symptomatology, but rather
that it is related to underlying differences on
social behaviour patterns. Men’s socially
unfavourable illness behaviour (e.g., low ac-
knowledgment of illness) would contribute
to their poorer social course and overall out-
come, whereas women’s higher tendency to
prosocial behaviour, such as cooperative-
ness and compliance, would influence a
more favourable outcome17. This pattern
would be consistent with research showing
that schizophrenic women have a better so-
cial functioning than schizophrenic men, re-
gardless of age of onset and symptomatol-
ogy18,19. In the biological domain, factors
such as later brain maturation in males are
hypothesised to render them more vulnera-
ble to prenatal and perinatal neurodevelop-
mental insults, which may cause structural
brain abnormalities that, in the case of schi-
zophrenia, have been associated to chronic
negative symptoms (i.e., residual status) and
premature onset. Additionally, it has been
suggested that estrogens may have a protec-
tive role for females by facilitating an earli-
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er maturation of the brain and, thus, making
them less vulnerable to neurodevelopmental
impairment20. Thus, men would be more
prone to a hypothesized poor-prognosis,
neurodevelopmental subtype of schizophre-
nia, for which early environmental brain in-
sults play an important etiologic role,
whereas women would be more prone to a
hypothesized good-prognosis, affective sub-
type, probably more genetically related to
affective disorders21.
Individuals who were single at onset also
showed poorer outcome (residual symptoma-
tology). Although results are not reported, sta-
tistical tests showed us that this association
was not due to age at onset, gender, premor-
bid adjustment, or continued contact with the
mental health service. Marital status (ever
married or lived with a stable partner) has
been shown to have an independent onset-de-
laying effect, even more marked in males,
which suggests that it is not earlier age of
onset (related to male gender) what prevents
individuals from getting married, but rather
that being married is what delays onset, and it
could as well prevent the emergence and
chronicity of residual symptomatology22.
Poor premorbid adjustment was significant-
ly associated to residual symptomatology.
This association seems to be developmentally
meaningful, as residual symptoms could be
understood as the continuation of the dysfunc-
tion already present before the psychotic exac-
erbation. Poor premorbid adjustment has
been associated with more negative symp-
toms in the early course of illness, less im-
provement in negative symptoms, and overall
poorer clinical and social functioning23; whe-
reas good premorbid adjustment has been re-
lated to better clinical outcome, not only in
chronic schizophrenia, but also in affective
psychoses (i.e. bipolar disorder, major de-
pression with psychosis)23 and in psychotic
disorders that are substance induced24.
Poor insight was also associated to poor
outcome, but this time defined by occurrence
of multiple psychotic episodes, not by residual
symptoms. This result is consistent with previ-
ous reports indicating that individuals experi-
encing a first episode of psychosis who have
little insight are at increased risk of discontin-
uing their medication25, disengaging from
treatment26, and thus increasing the chances
of relapse. In this study, though, insight and
continued contact with the mental health
service showed no significant association.
In this study, opposite to what was ex-
pected, none of the three dimensions of psy-
chopathology was associated with outcome.
Outcome in psychosis might well be pre-
dicted by baseline psychopathology, partic-
ularly by negative symptomatology27. Neg-
ative symptoms (e.g. social withdrawal and
anhedonia), rather than the characteristic
positive and even disorganization symptoms,
seem one of the strongest factors discriminat-
ing people who later develop schizophrenia
28,29. Moreover, the association of negative
symptoms at onset with later residual symp-
tomatology appears significant and even
stronger than their association with other di-
mensions of psychosis (e.g. psychoticism
and disorganization) or dimensions of pre-
morbid personality 30. It might be that in the
current study clinicians mostly focused on
the recording of the more striking positive
and disorganized symptoms, either because
of an assessment bias or because negative
symptoms at the time of first episode tend to
be masked by those symptoms that cause se-
vere behavioural disturbances.
Analysis of three outcome criteria
The three outcome criteria showed no sig-
nificant associations among them, suggest-
ing the relevance of using each of them to
map with completeness the course and out-
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come of first-episode psychosis. None of the
selected sociodemographic, premorbid, first-
episode or psychopathology variables could
significantly distinguish between patients
who developed schizophrenia from those
who had a different kind of psychosis. Al-
though the result could be due to insufficient
statistical power, an alternative possibility is
that none of these predictors is specifically
associated with schizophrenic or non-schiz-
ophrenic psychoses, which would be consis-
tent with research supporting that despite
schizophrenia, schizoaffective disorder, and
affective illness are prototypical entities,
they share common features and a general
set of aetiological and risk factors31,32.
Presence of residual symptoms was the
most distinguishable outcome from baseline
indicators. Over time, the treatment of
schizophrenia and related psychoses has
evolved, making the improvement of psy-
chosocial functioning and quality of life
feasible aims, in addition to the ameliora-
tion of positive symptoms33,34. However,
episode remission is not enough for recov-
ery because persistent symptomatology,
even if at a low level of severity, can inter-
fere with behaviour and functioning, hinder-
ing patients’ chances of social reintegra-
tion35. Thus, the possibility of identifying at
first-episode patients likely to suffer resid-
ual symptomatology has significant impli-
cations for treatment and service planning.
The number of relapses could only be as-
sociated with baseline level of insight. Re-
lapses have an important effect not only on
the clinical, but also on the social function-
ing of patients36. Exacerbation of symptoms
and hospitalizations might cause cumulative
deterioration in functioning and a dimin-
ished ability to maintain employment and re-
lationships35. Thus, early intervention treat-
ment programs in psychosis work hardly to
prevent relapses and to promote the mainte-
nance of a stable clinical status34. Abundant
research, replicated as well in the present
study, highlights the important role of in-
sight at illness onset as a prognostic factor37.
In summary, schizophrenia and other re-
lated psychoses cannot longer be seen as a
definite conviction to deterioration, as the
course of the disorder has shown to be het-
erogeneous. Here, three alternative defini-
tions of outcome were analysed: final diag-
nosis, presence of residual symptoms, and
number of psychotic episodes. Findings in-
dicate that being male, single marital status
at onset, poor premorbid adjustment, and
lack of insight are significant predictors of
“poor” outcome in the early course of first-
episode psychotic patients. Furthermore,
these factors better distinguish patients’ out-
come when this is defined as presence of
residual symptomatology. Thus, residual
symptomatology stands out as an important
measure of the outcome / course of the dis-
order and attention must be placed to its
standardized assessment and follow-up.
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